Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants
Translational and Clinical Pharmacology · 2026 · 34 (2) · 116
DOI: 10.12793/tcp.2026.34.e8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2026. Verfasst von Hyungji Jang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080,…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yuhan Corporation, Addpharma Co., Ltd..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.
- Yuhan R&D Institute, Yuhan Corporation, Yongin 17084, Korea.
ORCID-Profile: Hyungji Jang, Juyoung Khwarg, Ki Young Huh, Dong-Min Park, Heejung Park, Kyung-Sang Yu
Förderung
- Yuhan Corporation
- Addpharma Co., Ltd.
Zitieren
APA
Jang, H., Khwarg, J., Huh, K. Y., Park, D. M., Park, H., & Yu, K. S. (2026). Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. Translational and Clinical Pharmacology, 34(2), 116. https://doi.org/10.12793/tcp.2026.34.e8
Vancouver
Jang H, Khwarg J, Huh KY, Park DM, Park H, Yu KS. Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. Translational and Clinical Pharmacology. 2026;34(2):116. doi:10.12793/tcp.2026.34.e8
BibTeX
@article{Jang2026,
author = {Jang, Hyungji and Khwarg, Juyoung and Huh, Ki Young and Park, Dong-Min and Park, Heejung and Yu, Kyung-Sang},
title = {Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants},
journal = {Translational and Clinical Pharmacology},
year = {2026},
volume = {34},
number = {2},
pages = {116},
doi = {10.12793/tcp.2026.34.e8}
}
EUVIMED